These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3104105)

  • 1. Behavior of cutaneous Langerhans' cells and skin reactivity after gold sodium thiomalate treatment of pemphigus vulgaris.
    Blitstein-Willinger E
    Dermatologica; 1987; 174(2):68-75. PubMed ID: 3104105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HLA-DR and OKT6 antigens on keratinocytes and dendritic cells in pemphigus.
    Picut C; Meunier J; Lee C; Lewis R
    Arch Dermatol Res; 1987; 279(8):516-20. PubMed ID: 2449139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual expression of the cell-surface antigens HLA-DR and CD1 (T6) by Langerhans cells in human buccal mucosa and skin.
    Cruchley AT; Speight PM; Williams DM
    Arch Oral Biol; 1987; 32(11):849-53. PubMed ID: 2452627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
    de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
    J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
    Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
    Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UV sensitivity of human keratinocyte and Langerhans cell-expressed HLA-DR antigens: a comparison.
    Koulu L; Jansén CT
    Photodermatol; 1987 Aug; 4(4):176-81. PubMed ID: 2448759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells.
    Czernielewski JM; Schmitt D; Faure MR; Thivolet J
    Br J Dermatol; 1983 Feb; 108(2):129-38. PubMed ID: 6186266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study.
    Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK
    J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin.
    Ashworth J; Booker J; Breathnach SM
    Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans' cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells.
    Claudy AL; Rouchouse B
    Acta Derm Venereol; 1984; 64(4):334-6. PubMed ID: 6209893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OKT6 is not superior to HLA-DR or ATPase as a marker for Langerhans' cells in normal human epidermis.
    Liu HH; Schroeter AL; Muller SA
    Clin Exp Dermatol; 1986 May; 11(3):229-37. PubMed ID: 2943537
    [No Abstract]   [Full Text] [Related]  

  • 12. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration.
    Haftek M; Faure M; Schmitt D; Thivolet J
    J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Langerhans' cells in oral lichen planus using monoclonal antibodies.
    Sloberg K; Jonsson R; Jontell M
    J Oral Pathol; 1984 Oct; 13(5):516-24. PubMed ID: 6434718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
    Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
    J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of defective interleukin 1 and interleukin 2 production in patients with pemphigus vulgaris following chrysotherapy.
    Blitstein-Willinger E
    Clin Exp Immunol; 1985 Dec; 62(3):705-14. PubMed ID: 3936658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens).
    Hanau D; Fabre M; Schmitt DA; Garaud JC; Pauly G; Tongio MM; Mayer S; Cazenave JP
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2901-5. PubMed ID: 3106979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man.
    Faure M; Frappaz A; Schmitt D; Dezutter-Dambuyant C; Thivolet J
    Cell Immunol; 1984 Feb; 83(2):271-9. PubMed ID: 6229342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased number and function of antigen-presenting cells in the skin following application of irritant agents: relevance for skin cancer?
    Lisby S; Baadsgaard O; Cooper KD; Vejlsgaard GL
    J Invest Dermatol; 1989 Jun; 92(6):842-7. PubMed ID: 2786039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of cutaneous Langerhans cells of sarcoidosis patients.
    Fox JL; Berman B; Teirstein AS; France DS; Reed ML
    J Invest Dermatol; 1983 Jun; 80(6):472-5. PubMed ID: 6574191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-D region antigen expression by human epidermal Langerhans cells.
    Sontheimer RD; Stastny P; Nũnez G
    J Invest Dermatol; 1986 Dec; 87(6):707-10. PubMed ID: 3537146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.